⌘K

Login Start Free

Home/Filings/4/0000950170-25-020039

4//SEC Filing

Castelli Jeff 4

Accession 0000950170-25-020039

CIK 0001178879other

View on SEC.gov Company Profile

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 5:19 PM ET

Size

6.0 KB

Accession

0000950170-25-020039

Insider Transaction Report

Form 4

Period: 2025-02-11

AMICUS THERAPEUTICS, INC.FOLD

Chief Development Officer

Transactions

Tax Payment
Common Stock
2025-02-11$9.57/sh−22,724$217,469→ 465,476 total
Award
Common Stock
2025-02-11+52,338→ 488,200 total

Footnotes (1)

[F1]Granted for the achievement of the 2022 PRSUs as determined by the Board of Directors.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

AMICUS THERAPEUTICS, INC.

CIK 0001178879

Entity typeother

Related Parties

1

filerCIK 0001569225

Filing Metadata

Form type: 4
Filed: Feb 12, 7:00 PM ET
Accepted: Feb 13, 5:19 PM ET
Size: 6.0 KB

View on SEC.gov